IBD and skeletal health: Children are not small adults!

Inflammatory Bowel Diseases

Volumn 11, Issue 11, 2005, Pages 1020-1023

  Sylvester, Francisco A ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Farmington   (United States)

Author keywords

Bone mineral density; Children; Inflammatory bowel disease; Osteoporosis

Indexed keywords

BONE DENSITY; BONE MASS; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; ENTERITIS; FRAGILITY FRACTURE; HUMAN; INFLAMMATION; MALABSORPTION; MALNUTRITION; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WEIGHT BEARING;

AGE FACTORS; BONE AND BONES; BONE DENSITY; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FRACTURES, BONE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MALNUTRITION; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; WEIGHT-BEARING;

EID: 27644568111     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000188341.96726.15     Document Type: Review

References (36)

1. Gokhale R, Favus MJ, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114:902-911.
2. Semeao EJ, Jawad AF, Zemel BS, et al. Bone mineral density in children and young adults with Crohn's disease. Inflamm Bowel Dis. 1999;5:161-166.
3. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961-1968.
4. Gupta A, Paski S, Issenman R, et al. Lumbar Spine Bone Mineral Density at Diagnosis and During Follow-Up in Children With IBD. J Clin Densitom. 2004;7:290-295.
5. Harpavat M, Greenspan SL, O'Brien C, et al. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J Pediatr Gastroenterol Nutr. 2005;40:295-300.
6. Stains JP, Civitelli R. Cell-to-cell interactions in bone. Biochem Biophys Res Commun. 2005;328:721-727.
7. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
8. Seeman E. The growth and age-related origins of bone fragility in men. Calcif Tissue Int. 2004;75:100-109.
9. Parfitt AM, Travers R, Rauch F, et al. Structural and cellular changes during bone growth in healthy children. Bone. 2000;27:487-494.
10. Bachrach LK. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin North Am. 2005;34:521-535.
11. Herzog D, Bishop N, Glorieux F, et al. Interpretation of bone mineral density values in pediatric Crohn's disease. Inflamm Bowel Dis. 1998;4:261-267.
12. Khan AA, Bachrach L, Brown JP, et al. Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom. 2004;7:51-64.
13. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med. 2005;353:164-171.
14. Seligman JV, Basi SS, Deitel M, et al. Metabolic bone disease in a patient on long-term total parenteral nutrition: a case report with review of literature. JPEN J Parenter Enteral Nutr. 1984;8:722-727.
15. Croucher PI, Vedi S, Motley RJ, et al. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int. 1993;3:236-241.
16. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 2004;7:17-26.
17. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res. 2001;16:1658-1664.
18. Slemenda CW, Miller JZ, Hui SL, et al. Role of physical activity in the development of skeletal mass in children. J Bone Miner Res. 1991;6:1227-1233.
19. Rauch F, Bailey DA, Baxter-Jones A, et al. The 'muscle-bone unit' during the pubertal growth spurt. Bone. 2004;34:771-775.
20. Jahnsen J, Falch JA, Mowinckel P, et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2003;98:1556-1562.
21. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795-799.
22. Loftus EV Jr, Crowson CS, Sandborn WJ, et al. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology. 2002;123:468-475.
23. Loftus EV Jr, Achenbach SJ, Sandborn WJ, et al. Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. Clin Gastroenterol and Hepatol. 2003;1:465-473.
24. Semeao EJ, Stallings VA, Peck SN, et al. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology. 1997;112:1710-1713.
25. Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut. 2002;51:654-658.
26. Lin CL, Moniz C, Chambers TJ, et al. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology. 1996;111:1263-1271.
27. Dresner-Pollak R, Gelb N, Rachmilewitz D, et al. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology. 2004;127:792-801.
28. Hyams JS, Wyzga N, Kreutzer DL, et al. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr. 1997;24:289-295.
29. Varghese S, Wyzga N, Griffiths AM, et al. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr. 2002;35:641-648.
30. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315-323.
31. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309-319.
32. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402:304-309.
33. Ashcroft AJ, Cruickshank SM, Croucher PI, et al. Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity. 2003;19:849-861.
34. Byrne FR, Morony S, Warmington K, et al. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut. 2005;54:78-86.
35. Bernstein CN, Sargent M, Leslie WD. Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study. Inflamm Bowel Dis. 2005;11:325-330.
36. Franchimont N, Reenaers C, Lambert C, et al. Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol. 2004;138:491-498.